BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $859K invested in ProShares UltraShort NASDAQ Biotechnology in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

more funds holding

Funds holding: →

90% less call options, than puts

Call options by funds: $2K | Put options by funds: $21K

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
$21K
Net Calls
Net Calls Change

Top Buyers

1
+$179K
2
+$141K
3
+$11K

Top Sellers

1
-$4.57K
2
-$2.83K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$443K
2
$224K
3
$187K
4
$2.87K
5
$1.49K
6
$247